Back to search

France· FR:65358970

CASPOFUNGINE HIKMA 50 mg, poudre pour solution à diluer pour perfusion

A caspofungin product containing acétate de caspofungine, registered in France by HIKMA FARMACEUTICA (PORTUGAL). The same ATC class is registered in 18 of our 19 countries.

ATC J02AX04

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedCASPOFUNGINE HIKMA 50 mg, poudre pour…ATCJ02AX04REGISTER NO.FR:65358970PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Caspofungin is registered in 18 of 19 countries.

Countries holding a registration under ATC J02AX04 (caspofungin), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 10 of them publish a price we can compare per daily dose

Caspofungin · ATC J02AX04

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of caspofungin costs, country by country.

Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Caspofungin · price per daily dose (50 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$358.98
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ACÉTATE DE CASPOFUNGINE
Manufacturer
HIKMA FARMACEUTICA (PORTUGAL)
Country
France (FR)
ATC code
J02AX04
ATC class
Caspofungin
Defined daily dose
50 mg, P
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400930087732
    1 flacon(s) en verre de 50 mg

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

112 interactions on record for caspofungin.

Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Caspofungin · interactions on record

112 records

  • 6 severe
  • 35 moderate
  • 71 info

Most severe, free to view

  • DexamethasoneH02AB02severe
  • LeflunomidL04AA13severe
  • TeriflunomidL04AA31severe
  • LeflunomideL04AK01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Caspofungin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All caspofungin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Caspofungin Anfarm, Caspofungin Fresenius Kabi
  • Belgium · Caspofungin Fresenius Kabi, Caspofungin Sandoz
  • Bulgaria · Каспофунгин Ромфарм
  • Cyprus · Caspofungin Demo, Caspofungin Sapiens
  • Czechia · Caspofungin Demo
  • Germany · Caspofungin Demo, Caspofungin Eberth
  • Denmark · Casmyg, Caspofungin "sandoz"
  • Estonia · Caspofungin Sandoz
  • Spain · Caspofungin Demo, Caspofungina Demo
  • Finland · Caspofungin Demo S.A., Caspofungin Lorien
  • United Kingdom (Northern Ireland) · Caspofungin, Caspofungin Demo Pharmaceutical Industry
  • Greece · Casmyg, Caspofungin Anfarm
  • Croatia · Dalvocans, Kaspofungin Ligula Pharma
  • Hungary · Caspofungin Demo, Caspofungin Onkogen
  • Ireland · Caspofungin, Caspofungin Clonmel
  • Iceland · Cancidas, Caspofungin Stada
  • Italy · Caspofungi Hikma, Caspofungin Demo
  • Liechtenstein · Cancidas
  • Lithuania · Caspofungin Sandoz
  • Luxembourg · Caspofungine Noridem
  • Latvia · Caspofungin Pharmidea
  • Malta · Caspofungin Anfarm, Caspofungin Centrient Pharmaceutcials Netherlands
  • Netherlands · Caspofungine Cf, Caspofungine Demo
  • Norway · Cancidas, Caspofungin Demo S.A.
  • Poland · Caspofungin Adamed, Caspofungin Demo
  • Portugal · Caspofungina Farmoz, Caspofungina Generis
  • Romania · Caspofungină Demo, Caspofungină Kabi
  • Sweden · Caspofungin Demo S.A., Caspofungin Fresenius Kabi
  • Slovenia · Kaspofungin, Kaspofungin Teva
  • Slovakia · Caspofungin Demo, Caspofungin Sandoz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c0cd1ab5-22ea-44d8-ad33-a3b5a1a58c8c
GET /v1/drugs/c0cd1ab5-22ea-44d8-ad33-a3b5a1a58c8c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65358970",
  "date_amm": "2018-03-12",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "ACÉTATE DE CASPOFUNGINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre pour solution à diluer pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about caspofungin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.